Skip to content

The Effect of Vacuum Assisted Venous Drainage (VAVD) on Kidney Function and Blood Transfusion

The Effect of Vacuum Assisted Venous Drainage on Kidney Function and Blood Transfusion in Patients Undergoing Cardiac reoperation

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20230915059434N1
Enrollment
90
Registered
2023-10-14
Start date
2023-11-01
Completion date
Unknown
Last updated
2023-11-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiac reoperation.

Interventions

Intervention group: In the intervention group, by using the Polystan VAVD Controller and reducing the height difference between the patient and the venous reservoir, the length of the cardiopulmonary

Sponsors

Shaheed Rajaie Cardiovascular Medical and Research Center
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Patients who are candidates for cardiac reoperation Informed consent to participate in the study Age more than 18 years (Left Ventricular Ejection Fraction) LVEF greater than 35%

Exclusion criteria

Exclusion criteria: Presence of large vessel surgeries requiring Deep Hypothermic Circulatory Arrest (DHCA), third time reoperation and more Presence of kidney failure before surgery (patient with previous diagnosis of kidney failure or creatinine higher than 1.5 mg/dL) Presence of History of bleeding disorders before surgery Presence of Anemia before surgery (hemoglobin less than 10 gr/dL) Presence of history of cerebrovascular diseases

Design outcomes

Primary

MeasureTime frame
Serum creatinine level. Timepoint: Preoperatively, upon admission to the intensive care unit, 24 and 48 hours later. Method of measurement: laboratory test.

Secondary

MeasureTime frame
Blood Urea Nitrogen. Timepoint: Preoperatively, upon admission to the intensive care unit, 24 and 48 hours later. Method of measurement: laboratory test.;The amount of urinary output. Timepoint: During cardiopulmonary bypass, 6, 12, 24 and 48 hours after surgery. Method of measurement: Patient file information.;Central Venous Pressure. Timepoint: Before starting bypass, During and after the completion of cardiopulmonary bypass, upon entering the intensive care unit, 6, 12, 24 and 48 hours after surgery. Method of measurement: Patient monitoring information.;Mean Arterial Pressure. Timepoint: Before starting bypass, During and after the completion of cardiopulmonary bypass, upon entering the intensive care unit, 6, 12, 24 and 48 hours after surgery. Method of measurement: Patient monitoring information.;Prime volume used in cardiopulmonary bypass circuit. Timepoint: The volume of fluid used in the circuit at the start of cardiopulmonary bypass. Method of measurement: Patient file information.;Hemoglobin. Timepoint: Preoperatively, before starting bypass, during and after completion of cardiopulmonary bypass, upon admission to the intensive care unit, 6, 12, 24, and 48 hours after surgery. Method of measurement: laboratory test.;The amount of blood transfusion. Timepoint: Up to 48 hours after surgery. Method of measurement: Patient file information.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactZahra Majidi Parizi

Shaheed Rajaie Cardiovascular Medical and Research Center

zahra.majidiparizi@gmail.com+98 21 23921

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026